Latest News

Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose / image credit: ©New Africa/AdobeStock
Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose

March 14th 2024

Your daily dose of the clinical news you may have missed.

Risk of Stroke Mitigated by Even Low Levels of Physical Activity / image credit stroke: ©Puwadol Jaturawuttichai shutterstock
Risk of Stroke Mitigated by Even Low Levels of Physical Activity

March 12th 2024

Weak in the Legs Plus Dysgeusia: Seen in the ED / image credit doctor in the ED: ©Guschenkova stock.adobe.com
Weak in the Legs and Lips: Seen in the ED

March 8th 2024

Migraine, Persistent VMS Tied to Higher Risk of CVD, Stroke: Daily Dose / image credit: ©New Africa/AdobeStock
Migraine, Persistent VMS Tied to Higher Risk of CVD, Stroke: Daily Dose

March 8th 2024

Eli Lilly has announced that the US Food and Drug Administration's (FDA)  Peripheral and Central Nervous System Drugs Committee will convene for a meeting to deliberate over its antiamyloid therapy donanemab, and the supportive phase 3 TRAILBLAZER-ALZ 2 trial (NCT04437511).1 The date of the advisory meeting has yet to be set by the FDA, and, as a result, the timing of expected FDA action for the treatment will be delayed beyond the first quarter of 2024.1
Lilly Investigational Alzheimer Agent Donanemab Phase 3 Findings Under FDA Review

March 8th 2024

Video Interviews
Podcasts
Latest CME Events & Activities

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

BURST CME™: Taking ALS Management to the Next Level

View More

FAQs in MS: Exploring Provocative Questions From MS Meeting Updates

View More

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

View More

The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Facing the Challenges of Implementing Palliative Care

View More

Mastering MS: Translating Evidence into Optimal Management Plans

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Burst CME: Optimizing Therapy in Parkinson’s Disease

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

More News

© 2024 MJH Life Sciences

All rights reserved.